Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2016
PBS price cuts cruel pharm innovations
7 April 2016 - Earlier this week, pharmaceutical companies across the country received a substantial financial penalty, as the federal government’s ...
Posted by Michael Wonder on 11 Apr 2016
Closure of BEACH program after 18 years
11 April 2016 - The current contract with Australian Government Department of Health (DoH) for a partial contribution to the costs ...
Posted by Michael Wonder on 07 Apr 2016
PBAC Guidelines review update
7 April 2016 - The public consultation process on the draft revised PBAC Guidelines (Version 5.0) is now closed. ...
Posted by Michael Wonder on 04 Apr 2016
Medicines sector reforms deliver consumer benefits and a sustainable PBS
4 April 2016 - Consumers, taxpayers and the national health system will benefit from the significant savings being delivered by medicine ...
Posted by Michael Wonder on 04 Apr 2016
'Hundreds of cancer drugs' to enter market in next five years: report
4 April 2016 - Businessman Ron Walker considers himself among the luckiest cancer survivors. ...
Posted by Michael Wonder on 03 Apr 2016
Affordable access to innovative cancer medicines — don’t forget the prices
4 April 2016 - On 17 September 2015, the much anticipated Senate report on the Availability of new, innovative and specialist ...
Posted by Michael Wonder on 31 Mar 2016
Schedule of Pharmaceutical Benefits - 1 April 2016 update
1 April 2016 - The April 2016 issue of the Schedule sees a number of new/revised listings such as arsenic trioxide ...
Posted by Michael Wonder on 24 Mar 2016
Review of pharmacy remuneration and regulation - message from the Chair
24 March 2016 - Following his delivery of an informative presentation to pharmacists and industry at the Pharmacy Guild's 2016 Australian ...
Posted by Michael Wonder on 23 Mar 2016
The drug industry can help reduce cancer drug costs
21 March 2016 - Bach and colleagues’ article is particularly relevant because cancer drug expenditure is of major concern. ...
Posted by Michael Wonder on 22 Mar 2016
What can we expect from value-based funding of medicines? A retrospective study
22 March 2016 - Deciding on public funding for pharmaceuticals on the basis of value for money is now widespread. We ...
Posted by Michael Wonder on 22 Mar 2016
Confirmed 1 April 2016 prices resulting from 2016 April Cycle of Price Disclosure
22 March 2016 - Confirmed 1 April 2016 prices resulting from the 2016 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 20 Mar 2016
PBAC Drug Utilisation Sub Committee outcome statement
18 March 2016 - The outcome statement from the February 2016 PBAC Drug Utilisation Sub Committee (DUSC) meeting is now available ...
Posted by Michael Wonder on 19 Mar 2016
Additional public summary documents - PBAC November 2015 meeting
18 March 2016 - Additional public summary documents from the PBAC November 2015 meeting are now available on the PBS website. ...
Posted by Michael Wonder on 11 Mar 2016
PBS statutory pricing changes
11 March 2016 - The presentation slides from the 4 March 2016 information session on recent PBS statutory pricing changes have ...
Posted by Michael Wonder on 11 Mar 2016
PBAC Guidelines review
11 March 2016 - The assessment of co-dependent technology chapter of the draft revised PBAC Guidelines has now been published on ...